nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—narcolepsy	0.866	1	CbGaD
Pranlukast—IL5—Inflammatory Response Pathway—TNFRSF1B—narcolepsy	0.00572	0.0465	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—PENK—narcolepsy	0.00419	0.0341	CbGpPWpGaD
Pranlukast—MUC2—brainstem—narcolepsy	0.00336	0.297	CbGeAlD
Pranlukast—MUC2—forebrain—narcolepsy	0.00324	0.287	CbGeAlD
Pranlukast—IL5—Cytokines and Inflammatory Response—HLA-DRB1—narcolepsy	0.00304	0.0247	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—SOCS2—narcolepsy	0.00281	0.0228	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—SOCS2—narcolepsy	0.00241	0.0196	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00187	0.0152	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00187	0.0152	CbGpPWpGaD
Pranlukast—NFKB1—forebrain—narcolepsy	0.00185	0.163	CbGeAlD
Pranlukast—TNF—Monoamine Transport—HRH3—narcolepsy	0.00181	0.0147	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—HLA-DQA1—narcolepsy	0.00181	0.0147	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—P2RY11—narcolepsy	0.00181	0.0147	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—HLA-DQB1—narcolepsy	0.00169	0.0138	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00167	0.0136	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00167	0.0136	CbGpPWpGaD
Pranlukast—NFKB1—TNF receptor signaling pathway —TNFRSF1B—narcolepsy	0.00165	0.0134	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00162	0.0132	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—HCRT—narcolepsy	0.00154	0.0125	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00145	0.0118	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00145	0.0118	CbGpPWpGaD
Pranlukast—IL5—Cytokines and Inflammatory Response—TNF—narcolepsy	0.00144	0.0117	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0014	0.0114	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00138	0.0112	CbGpPWpGaD
Pranlukast—MUC2—brain—narcolepsy	0.00134	0.119	CbGeAlD
Pranlukast—IL5—Allograft Rejection—HLA-DRB1—narcolepsy	0.00129	0.0105	CbGpPWpGaD
Pranlukast—TNF—TNF receptor signaling pathway —TNFRSF1B—narcolepsy	0.00126	0.0102	CbGpPWpGaD
Pranlukast—NFKB1—Downstream TCR signaling—HLA-DQA1—narcolepsy	0.00124	0.0101	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00124	0.0101	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00124	0.0101	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0012	0.00974	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—TRH—narcolepsy	0.00117	0.00948	CbGpPWpGaD
Pranlukast—NFKB1—Downstream TCR signaling—HLA-DQB1—narcolepsy	0.00116	0.00945	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00104	0.00848	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNFRSF1B—narcolepsy	0.00102	0.0083	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00102	0.00828	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—SOCS2—narcolepsy	0.000978	0.00796	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TNFRSF1B—narcolepsy	0.000957	0.00778	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNFRSF1B—narcolepsy	0.000949	0.00772	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HCRTR1—narcolepsy	0.000944	0.00768	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HCRTR2—narcolepsy	0.000944	0.00768	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—HLA-DRB1—narcolepsy	0.00094	0.00765	CbGpPWpGaD
Pranlukast—NFKB1—TCR signaling—HLA-DQA1—narcolepsy	0.000928	0.00755	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—P2RY11—narcolepsy	0.000912	0.00742	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000908	0.00738	CbGpPWpGaD
Pranlukast—NFKB1—Downstream TCR signaling—HLA-DRB1—narcolepsy	0.000883	0.00718	CbGpPWpGaD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.000877	0.00713	CbGpPWpGaD
Pranlukast—NFKB1—TCR signaling—HLA-DQB1—narcolepsy	0.000868	0.00706	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—TAC1—narcolepsy	0.000847	0.00689	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—NPS—narcolepsy	0.000847	0.00689	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00079	0.00642	CbGpPWpGaD
Pranlukast—IL5—Immune System—SOCS2—narcolepsy	0.000786	0.00639	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TNFRSF1B—narcolepsy	0.000777	0.00632	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HCRT—narcolepsy	0.000776	0.00631	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000772	0.00628	CbGpPWpGaD
Pranlukast—NFKB1—brain—narcolepsy	0.000766	0.0678	CbGeAlD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000757	0.00616	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000757	0.00616	CbGpPWpGaD
Pranlukast—CYSLTR1—brain—narcolepsy	0.000753	0.0666	CbGeAlD
Pranlukast—IL5—GPCR downstream signaling—HCRTR2—narcolepsy	0.000744	0.00605	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HCRTR1—narcolepsy	0.000744	0.00605	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—TNFRSF1B—narcolepsy	0.000723	0.00588	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—P2RY11—narcolepsy	0.000718	0.00584	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—PENK—narcolepsy	0.000691	0.00562	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000677	0.0055	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HCRTR2—narcolepsy	0.000675	0.00549	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HCRTR1—narcolepsy	0.000675	0.00549	CbGpPWpGaD
Pranlukast—NFKB1—Canonical NF-kappaB pathway—TNF—narcolepsy	0.000663	0.00539	CbGpPWpGaD
Pranlukast—NFKB1—EBV LMP1 signaling—TNF—narcolepsy	0.000663	0.00539	CbGpPWpGaD
Pranlukast—NFKB1—TCR signaling—HLA-DRB1—narcolepsy	0.00066	0.00537	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.000657	0.00535	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—P2RY11—narcolepsy	0.000652	0.0053	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—HLA-DRB1—narcolepsy	0.000651	0.0053	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.000615	0.005	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HCRT—narcolepsy	0.000611	0.00497	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—TNF—narcolepsy	0.000608	0.00495	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—TRH—narcolepsy	0.000588	0.00478	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000561	0.00456	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000561	0.00456	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—HLA-DQA1—narcolepsy	0.00056	0.00455	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HCRT—narcolepsy	0.000555	0.00451	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000554	0.00451	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—PENK—narcolepsy	0.000544	0.00443	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000534	0.00434	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000534	0.00434	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—HLA-DQB1—narcolepsy	0.000524	0.00426	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—P2RY11—narcolepsy	0.000515	0.00419	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HRH3—narcolepsy	0.000515	0.00419	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—HTR2A—narcolepsy	0.000509	0.00414	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—TNF—narcolepsy	0.000509	0.00414	CbGpPWpGaD
Pranlukast—NFKB1—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—narcolepsy	0.000497	0.00404	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PENK—narcolepsy	0.000494	0.00402	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HCRTR1—narcolepsy	0.000485	0.00394	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HCRTR2—narcolepsy	0.000485	0.00394	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—P2RY11—narcolepsy	0.000468	0.00381	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000468	0.0038	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—TRH—narcolepsy	0.000463	0.00376	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000456	0.00371	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—TNF—narcolepsy	0.000453	0.00369	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HCRT—narcolepsy	0.000438	0.00356	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—TAC1—narcolepsy	0.000427	0.00347	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—NPS—narcolepsy	0.000427	0.00347	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000422	0.00343	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—TRH—narcolepsy	0.00042	0.00342	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—TNF—narcolepsy	0.00041	0.00333	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HRH3—narcolepsy	0.000406	0.0033	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HCRTR1—narcolepsy	0.000399	0.00324	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HCRTR2—narcolepsy	0.000399	0.00324	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—HLA-DRB1—narcolepsy	0.000398	0.00324	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HCRT—narcolepsy	0.000398	0.00324	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000394	0.0032	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—PENK—narcolepsy	0.000391	0.00318	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—P2RY11—narcolepsy	0.000385	0.00313	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000381	0.0031	CbGpPWpGaD
Pranlukast—NFKB1—TNF receptor signaling pathway —TNF—narcolepsy	0.000381	0.0031	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRH3—narcolepsy	0.000369	0.003	CbGpPWpGaD
Pranlukast—NFKB1—Ceramide signaling pathway—TNF—narcolepsy	0.000368	0.00299	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—TNF—narcolepsy	0.000356	0.0029	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PENK—narcolepsy	0.000355	0.00288	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—TNF—narcolepsy	0.000351	0.00285	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—narcolepsy	0.00034	0.00277	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000337	0.00274	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—NPS—narcolepsy	0.000336	0.00273	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—TAC1—narcolepsy	0.000336	0.00273	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TNF—narcolepsy	0.000335	0.00272	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000333	0.00271	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TRH—narcolepsy	0.000332	0.0027	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TNF—narcolepsy	0.00033	0.00268	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HCRT—narcolepsy	0.000328	0.00266	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SOCS2—narcolepsy	0.00032	0.0026	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—TAC1—narcolepsy	0.000305	0.00248	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—NPS—narcolepsy	0.000305	0.00248	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TRH—narcolepsy	0.000302	0.00245	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PENK—narcolepsy	0.000292	0.00237	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HRH3—narcolepsy	0.000291	0.00237	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HCRTR2—narcolepsy	0.000286	0.00233	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HCRTR1—narcolepsy	0.000286	0.00233	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TNF—narcolepsy	0.000285	0.00232	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—P2RY11—narcolepsy	0.000277	0.00225	CbGpPWpGaD
Pranlukast—NFKB1—Signaling events mediated by HDAC Class I—TNF—narcolepsy	0.000272	0.00221	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.000267	0.00217	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRH3—narcolepsy	0.000264	0.00215	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR2A—narcolepsy	0.000257	0.00209	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000254	0.00207	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—narcolepsy	0.000252	0.00205	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.00025	0.00203	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TRH—narcolepsy	0.000248	0.00202	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—NPS—narcolepsy	0.000241	0.00196	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TAC1—narcolepsy	0.000241	0.00196	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNF—narcolepsy	0.000235	0.00191	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000235	0.00191	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HCRT—narcolepsy	0.000235	0.00191	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—narcolepsy	0.000227	0.00184	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NPS—narcolepsy	0.000219	0.00178	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TAC1—narcolepsy	0.000219	0.00178	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—narcolepsy	0.000219	0.00178	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRH3—narcolepsy	0.000218	0.00177	CbGpPWpGaD
Pranlukast—IL5—Immune System—HLA-DQA1—narcolepsy	0.000215	0.00175	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PENK—narcolepsy	0.00021	0.0017	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR2A—narcolepsy	0.000202	0.00165	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.000201	0.00164	CbGpPWpGaD
Pranlukast—IL5—Immune System—HLA-DQB1—narcolepsy	0.000201	0.00163	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.00019	0.00154	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR2A—narcolepsy	0.000184	0.00149	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NPS—narcolepsy	0.00018	0.00147	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TAC1—narcolepsy	0.00018	0.00147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TRH—narcolepsy	0.000178	0.00145	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HCRTR2—narcolepsy	0.000162	0.00132	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HCRTR1—narcolepsy	0.000162	0.00132	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000157	0.00128	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—P2RY11—narcolepsy	0.000157	0.00127	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRH3—narcolepsy	0.000156	0.00127	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000154	0.00125	CbGpPWpGaD
Pranlukast—IL5—Immune System—HLA-DRB1—narcolepsy	0.000153	0.00124	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2A—narcolepsy	0.000145	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000144	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000143	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—narcolepsy	0.000135	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000135	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HCRT—narcolepsy	0.000133	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2A—narcolepsy	0.000132	0.00107	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NPS—narcolepsy	0.000129	0.00105	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TAC1—narcolepsy	0.000129	0.00105	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000122	0.000992	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PENK—narcolepsy	0.000119	0.000965	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2A—narcolepsy	0.000109	0.000882	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000105	0.000853	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000102	0.000832	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TRH—narcolepsy	0.000101	0.00082	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRH3—narcolepsy	8.85e-05	0.000719	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DQA1—narcolepsy	8.72e-05	0.00071	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DQB1—narcolepsy	8.16e-05	0.000664	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2A—narcolepsy	7.79e-05	0.000633	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TAC1—narcolepsy	7.33e-05	0.000596	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NPS—narcolepsy	7.33e-05	0.000596	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CHKB—narcolepsy	6.87e-05	0.000559	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DRB1—narcolepsy	6.21e-05	0.000505	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—narcolepsy	5.7e-05	0.000464	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CPT1B—narcolepsy	4.67e-05	0.00038	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CHKB—narcolepsy	4.53e-05	0.000369	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—narcolepsy	4.41e-05	0.000359	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CPT1B—narcolepsy	3.08e-05	0.00025	CbGpPWpGaD
